Treatment of Dyslipidemia Using CRISPR/Cas9 Genome Editing

被引:0
作者
Alexandra C. Chadwick
Kiran Musunuru
机构
[1] University of Pennsylvania,Cardiovascular Institute, Department of Medicine, Perelman School of Medicine
[2] University of Pennsylvania,Department of Genetics, Perelman School of Medicine
来源
Current Atherosclerosis Reports | 2017年 / 19卷
关键词
Genome editing; Dyslipidemia; CRISPR/Cas9; PCSK9; Cardiovascular disease;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 263 条
[1]  
Go AS(2013)Heart disease and stroke statistics—2013 update: a report from the American Heart Association Circulation 127 e6-e245
[2]  
Mozaffarian D(2017)Genome editing for the study of cardiovascular diseases Curr Cardiol Rep 19 22-20
[3]  
Roger VL(2017)Genome editing in cardiovascular diseases Nat Rev Cardiol 14 11-780
[4]  
Benjamin EJ(2017)Genome editing in cardiovascular biology Circ Res 120 778-823
[5]  
Berry JD(2013)Multiplex genome engineering using CRISPR/Cas systems Science 339 819-232
[6]  
Borden WB(2013)RNA-programmed genome editing in human cells elife 2 230-445
[7]  
Chadwick AC(2013)Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease Nat Biotechnol 31 435-15649
[8]  
Musunuru K(2003)Molecular views of recombination proteins and their control Nat Rev Mol Cell Biol 4 15644-1121
[9]  
Strong A(2013)Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis Proc Natl Acad Sci U S A 110 1116-191
[10]  
Musunuru K(2013)Orthogonal Cas9 proteins for RNA-guided gene regulation and editing Nat Methods 10 186-961